A subscription to JoVE is required to view this content. Sign in or start your free trial.
Not Published
Cancer cells can overcome replicative senescence by activating the alternative lengthening of telomeres (ALT) pathway. ALT positive cancer cells are uniquely characterized by the production of circular C-rich telomeric DNA sequences (C-circle). This protocol describes how to detect C-circles isolated from ALT-positive mammalian cells.
The identification of cancer cells that promote telomere elongation in the absence of telomerase activity led to the identification of the alternative lengthening of telomeres (ALT) pathway. The ALT pathway is active in approximately 10-15% of all human cancers. However, ALT is most prevalent in some of the most aggressive forms of human cancer including, glioblastoma, osteosarcoma, and pancreatic neuroendocrine tumors. These cancers are highly refractory to common therapeutic strategies and have poor overall survival. Therefore, there has been a growing interest in understanding how, and under what conditions, the ALT pathway is active in an effort to identify therapies that uniquely target the ALT mechanism. These efforts necessitate the use of a robust biomarker to not only identify ALT positive cancers, but also to monitor ALT activity throughout treatment. Several cellular phenotypes have been identified and demonstrated to correlate with ALT activity including the production of extrachromosomal telomeric repeat (ECTR) DNA. ECTR exist in both linear and circular forms containing either C-rich or G-rich partially double-stranded telomeric sequences. To date, the circular C-rich telomeric sequences (C-circles) are the only ECTR DNA products that have been demonstrated to be exclusive to ALT positive cancer cells. In this protocol, we demonstrate a technique used to isolate and detect C-circles from mammalian cells highlighting the utility of this assay in the determination of ALT status.
Telomeres are repetitive DNA sequences that cap the ends of linear chromosomes to protect chromosome ends from degradation and end-to-end fusions. Given the semiconservative nature of DNA replication telomeres shorten with each successive cell division. Eventually, telomeres reach a critically short length and induce cellular senescence and crisis. Cancer cells must overcome telomere shortening to bypass cellular senescence and gain replicative immortality.1 Approximately 85% of cancers promote telomere elongation by reactivating the enzyme telomerase.2 Another 10% of cancers activate a second mechanism called t....
1. Isolate genomic DNA
Cells that rely on the ALT pathway for telomere maintenance are characterized by a number of cellular phenotypes, including the formation of partially single-stranded circular C-rich telomeric DNA. C-circles are unique to ALT cells and can be detected using rolling circle amplification of genomic DNA isolated from mammalian cells as depicted in Figure 1. Figure 2A is a representative experiment demonstrating the detection C-circle products in the ALT positive U2OS and telomerase positive .......
The identification of cancer cells that maintain telomere length for over 100 population doublings in culture, in the absence of telomerase activity, led to the identification of the ALT pathway3. Since that initial discovery twenty years ago there has been a growing interest in defining mechanistically how, and under what conditions, the ALT pathway is active in cancer. To date, the literature suggests that the ALT pathway is active in approximately 10-15% of all human cancers, with the highest p.......
We thank members of the R.L.F. lab for review of the manuscript. R.L.F. is supported by the NIH Pathway to Independence Award (CA166729), the Karin Grunebaum Cancer Research Foundation, Peter Paul Professorship, and the Edward Mallinckrodt Jr. Foundation. E.M.O was also supported by the NIGMS T32 funded Program in Biomolecular Pharmacology (3T32GM008541-18S1).
....Name | Company | Catalog Number | Comments |
Microcentrifuge | Any microcentrifuge will work, eg. Eppendorf 5424 | ||
Nanodrop | Thermo Scientific | 2000 | Any DNA quantitation spectrophotometer is sufficient |
Water bath | A heat block can be used in place of a water bath for incubations | ||
Thermocycle | Any thermocycler is sufficient, e.g. BioRad C1000 touch | ||
Dot blot apparatus | BioRad | 1706545 | |
UV Crosslinker | Any UV Crosslinker is sufficient, e.g. Boekel Scientific 234100 | ||
Hybridization bags | Any boilable heat seal pouch will work, e.g. Kapak Sealpak  | ||
Hybridization oven | Any hybridization oven is sufficient, e.g. Thermo Scientific Shake 'n' Stack | ||
Glass hybridization bottle | Any hybridization bottle that fits the rotisserie in the hybridization oven, e.g. Wheaton borosilicate glass hybridization bottle | ||
Autoclave | |||
Chemiluminscent imager | Any chemiluminescence imager is sufficient, e.g. BioRad ChemiDoc XRS+with Image Lab software | ||
Impulse heat sealer | Any impulse heat sealer is sufficient, e.g. FS-305 impulse sealer | ||
D-PBS (1X) | Invitrogen | 14190-144 | Any PBS can be used to wash cell pellet |
0.05% Trypsin-EDTAÂ | Thermo Scientific | 25300062Â | Any cell dissociation reagent is sufficient, use reagent approriate for the cell line |
QIAmp DNA Mini kit | Qiagen | 51304 | |
Alu1 | New England Biolabs | R0137L | |
Mbo1 | New England Biolabs | R0147L | |
CutSmart Buffer (10X)Â | New England Biolabs | B7204S | Buffer is normally supplied with restriction enzymes |
PureLink Rnase A | Invitrogen | 12091-021 | |
GeneJET PCR Purification Kit | Thermo Scientific | K0701 | Qiagen QIAquick PCR purification kit can be used without effect on assay outcome |
Bovine Serum Albumin | Sigma | A2153 | Any BSA is sufficient |
phi29 DNA polymerase | New England Biolabs | MO269L | |
phi29 DNAÂ pol reaction buffer (10X) | New England Biolabs | BO269S | Buffer is normally supplied with polymerase |
Tween-20 | Sigma | P1379 | Any Tween 20 is sufficient |
dATP solution (100mM) | Invitrogen | 55082 | |
dTTP solution (100mM) | Invitrogen | 55085 | |
dGTP solution (100mM) | Invitrogen | 55084 | |
Sodium Chloride | Sigma | S5886 | Any sodium chloride is sufficient |
Sodium citrate tribasic dihydrate | Sigma | S4641 | |
Chromatography paper | Fisherbrand | 05-714-4 | Any chromatography filter paper is sufficient |
Amersham Hybond-XL | GE Healthcare | RPN 203 S | |
ULTRAHyb Ultrasensitive Hybridization buffer | Invitrogen | AM8670 | Warm in water bath to 65° C before use |
Sodium dodecyl sulfate | Fisher Scientific | BP166 | Any SDS is sufficient |
Telomere probe (5' - CCCTAACCCTAACCCTAACCCTAA - 3') | Invitrogen | 25nmoles; standard desalting; resuspend at 250µM | |
DIG oligonucleotide 3' - End labeling kit, 2nd generation | Roche | 3353575910 | Kit contains 5X reaction buffer, CoCl2 solution, DIG-ddUTP solution and recombinant terminal transferase |
EDTA | Sigma | 6381-92-6 | Any EDTA is sufficient |
Maleic Acid | Sigma | 110-16-7 | Any maleic acid is sufficient |
Blocking Reagent | Roche | 11096176001 | |
Tris-HCl | Sigma | 77-86-1 | Any Tris-HCl is sufficient |
anti-Digoxigenin-AP Fab fragments | Roche | 11093274910 | |
CDP-Star | Roche | 11759051001 |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved